SOPH Q2 2023 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$15M+29.0% YoY

Gross Profit

$10M66.7% margin

Operating Income

-$20M-133.2% margin

Net Income

-$21M-142.1% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$223M

Total Liabilities

$52M

Stockholders' Equity

$172M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$12M	+29.0%
Gross Profit	$10M	$8M	+31.9%
Operating Income	-$20M	-$24M	+16.7%
Net Income	-$21M	-$25M	+13.3%

Geographic Segments

Europe, The Middle East And Africa

$11M72%

North America

$2M17%

Latin America

$937,0006%

Asia Pacific

$846,0006%